DS-5565
DS-5565 is a pharmaceutical drug with 9 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 9 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
1
Mid Stage
7
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
100.0%
9 of 9 finished
0.0%
0 ended early
0
trials recruiting
9
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
DS-5565 Phase III Study for Renal Impairment in Japanese Subjects
Safety Study of DS-5565 for Treatment of Fibromyalgia Pain in Subjects With Chronic Kidney Disease
Treatment of Pain Associated With Fibromyalgia
Treatment of Pain Associated With Fibromyalgia
Treatment of Pain Associated With Fibromyalgia
Clinical Trials (9)
DS-5565 Phase III Study for Renal Impairment in Japanese Subjects
Safety Study of DS-5565 for Treatment of Fibromyalgia Pain in Subjects With Chronic Kidney Disease
Treatment of Pain Associated With Fibromyalgia
Treatment of Pain Associated With Fibromyalgia
Treatment of Pain Associated With Fibromyalgia
DS-5565 Phase III Study for Post-herpetic Neuralgia
DS-5565 Phase III Study for Diabetic Peripheral Neuropathic Pain
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Asian Phase 2 Study for Treatment of Pain Associated With Diabetic Peripheral Neuropathy
All 9 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 9